Yahoo Web Search

Search results

1. • • The average analyst rating for AVTX stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
     Reference:

     Avalo Therapeutics, Inc. (AVTX) Stock Forecast & Price ...

2. People also ask

   What did Avalo Therapeutics announce in the first quarter of 2024?

   • WAYNE, Pa. and ROCKVILLE, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced business updates and financial results for the first quarter of 2024. “Over the past month we have made considerable progress toward initiating our planned Phase 2 trial of AVTX-009 in hidradenitis suppurativa.

   Avalo Reports First Quarter 2024 Financial Results and Provides Busines…

   finance.yahoo.com/news/avalo-reports-first-quarter-2024-113000829.html

   See all results for this question

   Does Avalo Therapeutics (avtx) pay a dividend?

   • The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland. More... AVTX does not currently pay a dividend. Pie chart with 5 slices. End of interactive chart. Go Premium to see ratings on AVTX peers.

   Avalo Therapeutics, Inc. (AVTX) Stock Price, Quote, News & Analysis

   seekingalpha.com/symbol/AVTX

   See all results for this question

   Who is Avalo Therapeutics?

   • Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment of immune dysregulation. Avalo’s lead asset is AVTX-009, an anti-IL-1β mAb, targeting inflammatory diseases. Avalo’s pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

   Avalo Reports First Quarter 2024 Financial Results and Provides Busines…

   finance.yahoo.com/news/avalo-reports-first-quarter-2024-113000829.html

   See all results for this question

   How much money did Avalo make in first quarter 2024?

   • First Quarter 2024 Financial Update: As of March 31, 2024, Avalo had $110.2 million in cash and cash equivalents. In March 2024, the Company closed a private placement investment for up to $185.0 million in gross proceeds, including an initial upfront gross investment of $115.6 million.

   Avalo Reports First Quarter 2024 Financial Results and Provides Busines…

   finance.yahoo.com/news/avalo-reports-first-quarter-2024-113000829.html

   See all results for this question

3. www.marketbeat.com › stocks › NASDAQAvalo Therapeutics (AVTX) Stock Forecast and Price Target 2024

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   Apr 16, 2024 · According to the research reports of 2 Wall Street equities research analysts, The consensus rating for Avalo Therapeutics stock is Moderate Buy based on the current 1 hold rating and 1 buy rating for AVTX. Learn more on AVTX's analyst rating history.

   • Location: 540 Gaither Rd Ste 400, Rockville, Maryland 20850-6713
   • Email: ir@cerecor.com

   • Phone: (844) 978-6257
   • Employees: 19

4. finance.yahoo.com › quote › AVTXAvalo Therapeutics, Inc. (AVTX) Stock Price, News, Quote ...

   finance.yahoo.com › quote › AVTX

   • Cached

   Volume 15,872. Avg. Volume 700,340. Market Cap (intraday) 11.903M. Beta (5Y Monthly) 1.22. PE Ratio (TTM) -- EPS (TTM) -51.00. Earnings Date Aug 1, 2024 - Aug 5, 2024. Forward Dividend & Yield --...

5. Videos

   • 

     4:10

     youtube.com

     $AVTX STOCK UPDATE! THIS IS BIG NEWS FOR AVALO THERAPEUTICS HOLDERS!

     Oct 5, 2023

   • 

     12:09

     youtube.com

     AVTX Stock - Avalo Therapeutics 🚨 The Next Massive Stock Runner - MUST WATCH - $AVTX

     Oct 15, 2023

     3.2K Views

   • 

     7:10

     youtube.com

     AVTX Stock Analysis! Avalo Therapeutics Stock News! $AVTX 9/24/2023

     Sep 24, 2023

     324 Views

   View all

6. stockanalysis.com › stocks › avtxAvalo Therapeutics, Inc. (AVTX) Stock Forecast & Price ...

   stockanalysis.com › stocks › avtx

   • Cached

   13.10. +1.95 (17.49%) At close: May 24, 2024, 4:00 PM. 12.14. -0.96 (-7.33%) After-hours:May 24, 2024, 7:44 PM EDT. Overview. Financials. Statistics. Forecast. Profile. Chart. Forecast. Analyst Ratings. Avalo Therapeutics Stock Forecast. All Analysts. Top Analysts.

7. finance.yahoo.com › news › avalo-reports-firstAvalo Reports First Quarter 2024 Financial Results and ...

   finance.yahoo.com › news › avalo-reports-first

   • Cached

   May 13, 2024 · Avalo Therapeutics. Topline results from planned Phase 2 trial of AVTX-009 in hidradenitis suppurativa expected in 2026. Cash on hand of approximately $110 million as of March 31, 2024 with...

8. www.wallstreetzen.com › stocks › usAvalo Therapeutics Stock Forecast & Predictions: 1Y Price ...

   www.wallstreetzen.com › stocks › us

   • Cached

   Is Avalo Therapeutics Stock a good buy in 2024, according to Wall Street analysts? The consensus among 1 Wall Street analyst covering ( NASDAQ : AVTX ) stock is to Buy AVTX stock. Out of 1 analyst , 0 ( 0% ) are recommending AVTX as a Strong Buy, 1 ( 100% ) are recommending AVTX as a Buy, 0 ( 0% ) are recommending AVTX as a Hold, 0 ( 0% ) are ...

9. finance.yahoo.com › news › avalo-therapeutics-avtxAvalo Therapeutics (AVTX) Surges 270% in a Week: Here's Why

   finance.yahoo.com › news › avalo-therapeutics-avtx

   • Cached

   Apr 2, 2024 · Zacks Equity Research. Tue, Apr 2, 2024, 11:30 AM 4 min read. In this article: ADMA. ANIP. Avalo Therapeutics AVTX is a clinical-stage biotechnology company focused on developing therapies...

10. seekingalpha.com › symbol › AVTXAvalo Therapeutics, Inc. (AVTX) Stock Price, Quote, News ...

    seekingalpha.com › symbol › AVTX

    • Cached

    May 22, 2024 · Valuation. Growth. Profitability. Momentum. Peers. Options. Charting. AVTX Stock Price. -98.50% May 2024 Mar 2024 Jan 2024 Nov 2023 Sep 2023 Jul 2023 0 250 500 750 1,000 1,250. 52 Week Range....